Behavioral variations between male and female animals have been noted, stemming from differences in the nervous system's structure, physiology, and brain chemistry (
14). Research has indicated that gender impacts behavioral assessments in several ways, including variations in serotonergic activity across different brain regions and the influence of distinct sex hormones (
15). Such differences are also evident in the FST (
3). Female rats exhibited more swimming behavior than males during the pre-test but demonstrated increased floating time during the primary test. Conversely, male rats displayed more climbing behavior in pre-test and main-test sessions (
15). In female rats, the induction of chronic stress through isolation and restraint during adolescence reduced active behaviors in the FST, whereas it had no impact on male rats (
16). However, results vary, with some studies finding no gender differences in behaviors among Brown-Norway, Fisher 344, Lewis, WKY, and spontaneously hypertensive strains (
17,
18). Gender-related differences in response to drug interventions in the FST have also been reported. One study found that the antidepressant effect of desipramine was significantly more significant in male rats than female rats (
19). Chronic treatment with clomipramine, another tricyclic antidepressant, proved effective in male rats exhibiting novelty-seeking behaviors but did not affect females under similar conditions (
20). Female rats on a creatine-enriched diet showed increased activity in the FST, whereas male rats did not exhibit any changes (
21). Therefore, it is recommended to consider the gender of animals when studying the effects of various drugs and, if possible, to include both sexes in the research (
3).